We found that the ability to detect ZIKVRNAin saliva was higher compared to blood; was neither found to be related to a particular clinical presentation nor to the age of the patient. The use of saliva improved the ability to detect ZIKV RNA within the first week from symptoms onset but it did not increase the window of detection in contrast to what was reported for urine.